Gastrointestinal Transit and Motility in Renal Transplant Recipients
Study Details
Study Description
Brief Summary
Gastrointestinal (GI) complications after renal transplantation are commonly reported as side effects of immunosuppressive agents. Despite this, motility disorders have been scantily studied. Alternating Current Biosusceptometry (ACB) are biomagnetic sensors designed for a wide range of applications. In clinical practice, their non-invasive and radiation free features provide an excellent approach for monitoring of GI transit as alternative to scintigraphy and breath tests. The aim of this study is to examine GI transit and motility of solids in stable renal transplant recipients to determine the potential influence of immunosuppressive therapy on gastrointestinal parameters.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Tacrolimus Influence of tacrolimus on gastrointestinal transit and motility in renal transplant recipients. |
|
Cyclosporine Influence of cyclosporine on gastrointestinal transit and motility in renal transplant recipients. |
|
Mycophenolate mofetil Influence of mycophenolate mofetil on gastrointestinal transit and motility in renal transplant recipients. |
|
Mycophenolate sodium Influence of mycophenolate sodium on gastrointestinal transit and motility in renal transplant recipients. |
|
Everolimus Influence of everolimus on gastrointestinal transit and motility in renal transplant recipients. |
|
Sirolimus influence of sirolimus on gastrointestinal transit and motility in renal transplant recipients. |
|
Without immunosuppression Gastrointestinal transit and motility in healthy volunteers. |
Outcome Measures
Primary Outcome Measures
- Influence of tacrolimus and cyclosporine on gastrointestinal transit [one year]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Healthy Volunteer or Renal Transplant Patients
-
Signed informed consent obtained
-
Fasted since midnight
Exclusion Criteria:
-
Subject has known GI related symptoms complaints or GI diseases
-
Subject has cancer or other life threatening diseases or conditions
-
Subject is pregnant
-
Subject has undergone abdominal surgery
-
Drug abuse or alcoholism
-
Subject has cardiac pacemaker
-
Subject takes any medication affecting GI motility
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Universidade Estadual de Ciências da Saúde de Alagoas | Maceio | Alagoas | Brazil | 57010382 |
Sponsors and Collaborators
- Universidade Estadual de Ciências da Saúde de Alagoas
- UPECLIN HC FM Botucatu Unesp
- University of Sao Paulo
Investigators
- Principal Investigator: Maria do Carmo B Teixeira, Dr, Universidade Estadual de Ciências da Saúde de Alagoas
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- FAPEAL-20110714-TX